- CIIX leverages its robust financial expertise to become leader in nascent Chinese CBD market
- CEO discusses potential health benefits of CBD-based products as China – and world – faces spread of coronavirus
- Wang emphasizes tremendous opportunities offered by CBD Biotech’s products in enormous yet untapped CBD Chinese market
California-based ChineseInvestors.com Inc. (OTCQB: CIIX) is a financial-news media and content platform founded in 1999 that has become a leading financial information platform for Chinese-speaking investors in the United States and China. Recognizing exceptional opportunities in the emerging cannabis industry, CIIX is leveraging its tremendous financial expertise to establish itself as a leader in China’s developing cannabidiol (CBD) industry.
Although cannabis is currently illegal in China, hemp-based CBD can be legally added to nutrition and health products and cosmetics, opening up massive opportunities in the untapped Chinese CBD market. CIIX has created a three-year development plan to pioneer an attractive lineup of CBD-based products through its subsidiary, CBD Biotech, and capitalize on the tremendous potential of the enormous Chinese market, where the benefits of CBD oil have not been widely recognized yet.
In addition, in a bid to meet growing consumer expectations for seamless digital customer experiences, the company is developing a CBD-focused platform for Chinese people to review and discuss various CBD products. The platform is intended to be a Yelp-style mobile app and will be the first CBD social-media mobile app that caters to Chinese-speaking customers worldwide. The company has already launched another digital product, www.ChineseCBDoil.com, the world’s first online, CBD-infused, health-products store in Chinese.
A growing number of Chinese people are becoming aware of the numerous health benefits of CBD oil for the treatment of a number of conditions such as stress, anxiety, poor sleep, Alzheimer’s disease and more. In a recent interview with MoneyTV’s Donald Baillargeon, CIIX CEO Warren Wang discussed health benefits of CBD-based products offered by CIIX, emphasizing those that are relevant in the current environment where the coronavirus is an international concern.
Speaking to MoneyTV’s vast audience, which numbers over 200 million households in more than 75 countries, Wang said that the need for health-related products to potentially address the virus that originated in the Chinese province of Wuhan presents a tremendous opportunity for CBD Biotech. The innovative lineup of the company’s CBD health and cosmetics products may be particularly helpful when the world, and China in particular, are under the threat of the virus. Among others, Wang mentioned the company’s hemp-infused soap and also noted CBD Biotech is planning to roll out the first hemp-infused protective face mask.
“I’m not a doctor; I cannot say that CBD can help your immune system, but I speak from my three-year experience,” Wang stated in the interview (http://ibn.fm/CZWAT), indicating that seeking medical help is essential while CBD products can be a preventative measure. “I am the first one in the public market field inside China selling CBD. In the long run, we have tremendous opportunities. You can call me the number-one CBD salesman in China.”
The CIIX business model is based on the sound business strategy of diversifying income streams between attractive business lines that, although separate, are centered around Chinese investors or consumers, making the company an attractive investment opportunity. Particularly compelling as the company has announced a Nasdaq IPO planned for the beginning of 2020, CIIX can bring investors benefits of early entrance in the company with a sound, diversified business model and enormous target market that offers significant opportunities.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX